Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged infringement · clear
LED colossus Nichia (the world’s largest supplier of LEDs) accused Everlight of infringing three patents relating to tiny LEDs used in LCD backlights, video displays, automobiles, an general lighting: U.S. Patent No. 8,530,250 , entitled “Light…
Written by Peter Heuser, Schwabe Williamson & Wyatt In Nichia the Circuit affirms the denial of a permanent injunction because Nichia failed to prove irreparable injury. In RecogniCorp the panel throws out as not being directed to patentable subject matter…
Last week Docket Navigator delivered a troubling headline regarding a recent District Court decision – “ Invalidity Opinion Delivered After Product Launch No Defense to Willful Infringement. ” As a practitioner who regularly drafts…
Guest Post: SCA v. First Quality With TC Heartland still on deck a the Supreme Court, a look back at the Court's most recent patent decision SCA v. First Quality by guest poster, Gary Cohen. Some of my thoughts, are posted on IPwatchdog ( here ). Back…
Written by Rebecca L. Wright , Ph.D. and Jonathan Hyman Edited by Loni Morrow and Catherine Holland Airwair, the owner of the Dr. Martens brand, recently launched a series of lawsuits in the Northern District of California to enforce the trade dress of its…
Written by Peter Heuser, Schwabe Williamson & Wyatt In Nidec v. Zhongshan , the panel reverses a determination of anticipation, noting that the Circuit’s Kennametal case does not stand for the proposition that anticipation can be found even when a…
Last month, the Federal Circuit issued its opinion in Shire Development v. Watson Pharmaceuticals, finding that Watson’s generic version of LIALDA® did not infringe U.S. patent 6,773,720 (“the ‘720 patent”). In particular, the…
Last week, the Delaware district court granted Aurobindo’s motion for summary judgment of non-infringement of Reckitt’s patents directed to a “modified release drug product” containing a sustained-release formulation of guaifenesin…
It has been a busy week at the Circuit. In Comcast v. Sprint the Circuit affirms a $7.5 million ‎judgment that includes prejudgment interest running from the date of the first-to-issue patent ‎instead of apportioning the interest based on the issue…
Written by Jeffrey C. Wu, Ph.D. and Brenden S. Gingrich, Ph.D. I. Summary The Supreme Court in Life Technologies Corp. v. Promega Corp. held that providing a single component of a multicomponent invention for manufacture abroad does not give rise to patent…
In Life Technologies Corp. v. Promega Corp. [14-1538] (February 22, 2017), the Supreme Court reversed a Federal Circuit decision that supplying a single component of a multi-component invention from the United States is an infringing act under Patent Act…
The real news this past week is not from the Circuit but from the Supreme Court’s reversal of the Life Technologies v. Promega case. There, the Supreme Court reversed the ‎Circuit’s ruling that shipping a single component of a ‎claimed…
